SanMing First Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Colorectal cancer1 trial
• Liver and biliary tract cancer1 trial
• Stroke1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Ruijin Hospital2 trials
• Fujian Medical University Union Hospital1 trial
• Wan-Jin Chen1 trial

Running trials

• Recruiting

  Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

  NCT07331883· Phase 2· Ruijin Hospital· Source

  Contact: Xiaokang Fu

• Recruiting

  Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

  NCT07296705· Phase 2· Fujian Medical University Union Hospital· Source

  Contact: Dongming Lu

• Recruiting

  Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

  NCT07085169· Phase 2· Ruijin Hospital· Source

  Contact: Chen-Fei Zhou, MD, Ph.D

• Active, not recruiting

  Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

  NCT06360458· Phase 3· Wan-Jin Chen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Colorectal cancer1 recruiting
• Liver and biliary tract cancer1 recruiting